Proinflammatory and estrogen signaling modulates the chemoresistance and metastasis of breast cancer cells through post-translational modifications of pioneering factor FOXA1

被引：0
|
作者：
Li, Shen
Franco, Hector L.
Kim, Hyunsoo
Plagens, Rosemary N.
Mendez-Giraldez, Raul
Tubbs, Colby
Malladi, Venkat
Garay, Joseph
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P6-12-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-12-03
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6
    Yamaguchi, Noritaka
    Nakayama, Yuji
    Yamaguchi, Naoto
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (20) : 8136 - 8148
  • [42] Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
    Chrysostomi Gialeli
    Emre Can Tuysuz
    Johan Staaf
    Safa Guleed
    Veronika Paciorek
    Matthias Mörgelin
    Konstantinos S. Papadakos
    Anna M. Blom
    Journal of Experimental & Clinical Cancer Research, 42
  • [43] Integrative proteomics of PARP1 protein complexes and post-translational modifications implicates DDR and AKT-mTOR signaling in mediating response or primary resistance of ovarian carcinoma cells to PARP1 inhibitors
    Deng, Ou
    Dash, Sweta
    Nepomuceno, Thales
    Fang, Bin
    Marchion, Douglas
    Koomen, John
    Monteiro, Alvaro N.
    Rix, Uwe
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [44] Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway
    Wu, Hao
    Chu, Yijun
    Sun, Shanshan
    Li, Guozheng
    Xu, Shouping
    Zhang, Xianyu
    Jiang, Yongdong
    Gao, Song
    Wang, Qin
    Zhang, Jian
    Pang, Da
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [45] An important role for AIB1 phosphorylation in mediating growth factor signaling dependent estrogen agonist activity of tamoxifen in breast cancer cells.
    Shou, J
    Choudhury, P
    Chamness, G
    Osborne, K
    Schiff, R
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S200 - S200
  • [46] Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die
    Onyeagucha, Benjamin
    Subbarayalu, Panneerdoss
    Abdelfattah, Nourhan
    Rajamanickam, Subapriya
    Timilsina, Santosh
    Guzman, Rosa
    Zeballos, Carla
    Eedunuri, Vijay
    Bansal, Sanjay
    Mohammad, Tabrez
    Chen, Yidong
    Vadlamudi, Ratna K.
    Rao, Manjeet K.
    ONCOTARGET, 2017, 8 (49) : 85984 - 85996
  • [47] Insulin-Like Growth Factor I Promotes Estrogen Receptor Positive Breast Cancer Cell Proliferation, in Part, through CYP1A1 Signaling.
    Rodriguez, M.
    Becker, M.
    Yee, D.
    Potter, D.
    CANCER RESEARCH, 2011, 71
  • [48] Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells
    Lin, Cheng-Wei
    Sun, Min-Siou
    Liao, Mei-Ying
    Chung, Chu-Hung
    Chi, Yi-Hsuan
    Chiou, Li-Tin
    Yu, John
    Lou, Kuo-Lung
    Wu, Han-Chung
    CARCINOGENESIS, 2014, 35 (11) : 2425 - 2435
  • [49] FOXP1, an Estrogen-Inducible Transcription Factor, Modulates Cell Proliferation in Breast Cancer Cells and 5-Year Recurrence-Free Survival of Patients with Tamoxifen-Treated Breast Cancer
    Shigekawa T.
    Ijichi N.
    Ikeda K.
    Horie-Inoue K.
    Shimizu C.
    Saji S.
    Aogi K.
    Tsuda H.
    Osaki A.
    Saeki T.
    Inoue S.
    Hormones and Cancer, 2011, 2 (5): : 286 - 297
  • [50] Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells -: Relationship to transforming growth factor-β1 signaling
    Fanayan, S
    Firth, SM
    Baxter, RC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7255 - 7261
12345